BMJ

Efficacy of physiotherapy management of knee joint osteoarthritis: a randomised, double blind, placebo controlled trial

1 Centre for Health, Exercise and Sports Medicine, School of Physiotherapy, University of Melbourne, Parkville, Victoria, Australia 2 Monash Department of Clinical Epidemiology, Cabrini Hospital and ...
BMJ

Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities

Only a minority of patients with eosinophilic granulomatosis with polyangiitis (EGPA) can be weaned-off glucocorticoids (GC) using conventional treatment strategies. The development of biological ...
BMJ

Remission in systemic lupus erythematosus: durable remission is rare

Introduction Remission is the ultimate goal in systemic lupus erythematosus (SLE). In this study, we applied four definitions of remission agreed on by an international collaboration (Definitions of ...
BMJ

Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis

1 Department of Rheumatology, University College London Hospitals, Arthur Stanley House, 40-50 Tottenham Street, London W1T 4NJ, UK 2 Institute of Nuclear Medicine, University College London Hospitals ...
BMJ

AB0727 Increased Rates of Hypertension in Patients with Psoriatic Arthritis Compared To Psoriasis Alone: Results from The UK Biobank

1 Arthritis Research UK Centre for Genetics and Genomics, Manchester Academic Health Science Centre 2 Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester ...
BMJ

Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification

1 Peking University China-Japan Friendship School of Clinical Medicine, Beijing, People's Republic of China Correspondence to Dr Qinglin Peng, Department of Rheumatology, Key Lab of Myositis, ...
BMJ

Scoring hypoechogenic areas in one parotid and one submandibular gland increases feasibility of ultrasound in primary Sjögren’s syndrome

Correspondence to Professor Hendrika Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen 9713 GZ, The Netherlands; h.bootsma{at}umcg.nl ...
BMJ

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus

1 Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA 2 Sjögren's Syndrome Clinic, Molecular ...
BMJ

Assessing the performance of AI chatbots in answering patients’ common questions about low back pain

Objectives The aim of this study was to assess the accuracy and readability of the answers generated by large language model (LLM)-chatbots to common patient questions about low back pain (LBP).
BMJ

An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series

Background In inflammatory bowel disease (IBD), a new biological therapy has recently been approved. Vedolizumab is a humanised IgG1 monoclonal antibody to α4β7 integrin that modulates gut lymphocyte ...
BMJ

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Correspondence to Professor Jérôme Avouac, Department of Rheumatology, Paris Descartes University, Cochin Hospital, Paris 75014, France; javouac{at}me.com Their main disease characteristics are ...
BMJ

Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland

We read with interest the recent article by Singh and Cleveland on the hypersensitivity risk of allopurinol (ALP) and febuxostat (FBX) compared with colchicine.1 A common challenge when using ALP, ...